Choosing wisely: a model-based analysis evaluating the trade-offs in cancer benefit and diagnostic referrals among alternative HPV testing strategies in Norway
Background: Forthcoming cervical cancer screening strategies involving human
papillomavirus (HPV) testing for women not vaccinated against HPV infections may increase …
papillomavirus (HPV) testing for women not vaccinated against HPV infections may increase …
Decreasing Trends in Cervical Cancer Incidence among Young Women (15–34 Years) in the United States during the Human Papillomavirus (HPV) Vaccine Era
F Guo, LE Cofie, AB Berenson - Cancer Epidemiology, Biomarkers & …, 2017 - AACR
Human papillomavirus (HPV) vaccine has been recommended for girls 11–12 years of age
since 2006, with catch-up vaccination up to 26 years, to protect against most common types …
since 2006, with catch-up vaccination up to 26 years, to protect against most common types …
Role of human papillomavirus DNA load in predicting the long-term risk of cervical cancer: a 15-year prospective cohort study in China
X Zhao, S Zhao, S Hu, K Zhao, Q Zhang… - The Journal of …, 2019 - academic.oup.com
Background Biomarkers highly predictive of cervical cancer are urgently needed for triaging
human papillomavirus (HPV)–positive women. Methods A total of 1997 women aged 35–45 …
human papillomavirus (HPV)–positive women. Methods A total of 1997 women aged 35–45 …
Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway
EA Burger, JD Ortendahl, S Sy, IS Kristiansen… - British journal of …, 2012 - nature.com
Background: New screening technologies and vaccination against human papillomavirus
(HPV), the necessary cause of cervical cancer, may impact optimal approaches to prevent …
(HPV), the necessary cause of cervical cancer, may impact optimal approaches to prevent …
HPV prevalence among women from Appalachia: results from the CARE project
Background Cervical cancer incidence and mortality rates are high among women from
Appalachia, yet data do not exist on human papillomavirus (HPV) prevalence among these …
Appalachia, yet data do not exist on human papillomavirus (HPV) prevalence among these …
Global cervical Cancer incidence by histological subtype and implications for screening methods
Background Cervical cancer is a major global health concern, disproportionately affecting
women in developing countries. Cervical cancer has two primary subtypes, squamous cell …
women in developing countries. Cervical cancer has two primary subtypes, squamous cell …
Calibration of a natural history model of cervical cancer using longitudinal primary data
JJ Kim, KM Kuntz, J Goldhaber-Fiebert… - … and abstracts of the …, 2004 - smdm.confex.com
Purpose: The multi-step model of cervical cancer pathogenesis involves, as the first step,
infection with high-risk types of human papillomavirus (HPV). Many women with transient …
infection with high-risk types of human papillomavirus (HPV). Many women with transient …
[PDF][PDF] HPV Screening in the way to cervical cancer elimination
M Arbyn - HPV World, 2018 - hpvworld.com
What has been your area of expertise in relation to HPV screening? Currently our main
expertise comprises synthesizing the evidence related to prevention and treatment of HPV …
expertise comprises synthesizing the evidence related to prevention and treatment of HPV …
Five-year cervical (pre) cancer risk of women screened by HPV and cytology testing
MH Uijterwaal, NJ Polman, FJ Van Kemenade… - Cancer Prevention …, 2015 - AACR
Primary human papillomavirus (HPV)–based cervical screening will be introduced in the
Netherlands in 2016. We assessed the 5-year cervical (pre) cancer risk of women with …
Netherlands in 2016. We assessed the 5-year cervical (pre) cancer risk of women with …